about
Molecular mechanisms underlying occult hepatitis B virus infection.Occult hepatitis B virus and hepatocellular carcinomaA pilot study on screening blood donors with individual-donation nucleic acid testing in China.Occult hepatitis B viral infection among blood donors in South-Eastern NigeriaProspects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus.Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China.Occult HBV infection.Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infectionOccult hepatitis B virus infection among Egyptian blood donors.Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA.Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors.Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City.Hepatitis B escape mutants in Scottish blood donors.Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients.Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc TestingHigh prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.Infectivity of blood products from donors with occult hepatitis B virus infection.The clinical significance of occult HBV infection.Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report.
P2860
Q27686923-A4B2DA40-EC66-42E5-9BF4-4FCECC13F54DQ33661018-E279D568-C467-4B6F-8BC6-C09B4091161FQ33690837-D160B929-F92B-4678-946D-AE0C4616639AQ34129673-F4F9507A-DFBA-4267-9AA9-0ED80685B0E2Q34428554-43D0E8B8-1CD2-4619-8D6A-A673E7CB4D15Q36137790-0CDC42CB-7D70-43F9-A02D-0CB5B6252912Q36518847-DEA1527A-3312-40BF-A2A2-06DFC2188680Q36654281-EF5766F2-E1C3-439C-9888-EBB8A9EA39B8Q36766479-FC8AF20D-4518-40ED-B585-8C3326251FC1Q36812851-C04F8678-CFB6-431E-8ACD-96C078BE7EC7Q37232154-F2CDC371-BA77-4A1F-9992-75D44D7E6039Q37423887-96067869-C7C0-4E50-8C34-AF0B7701C8B7Q37602298-05B29881-ED0D-4272-AEC1-AB7977B4DFB7Q38536404-2C14A998-FE83-4C5C-B078-897CC3155D0AQ38852641-DC054632-2758-4FB4-B3F1-B2BC534C8765Q39219129-34167E52-6A3C-435D-989C-11CAA0543FB4Q39384102-06831FD1-3DEC-4672-B97C-7AC6D512C4E1Q41111337-61BFD6A7-2B65-4CC7-9C22-D02787A3C037Q41680549-B9128710-A9DB-4F3C-8ACD-B40C7CDA7CD4Q42173073-BB4D68A3-C46B-494E-B54B-7721D4E12A75Q42258103-4C3EFCEE-ABF2-4BCD-B89F-B51E00CA056BQ42277057-61BA6AC6-3E69-4A20-82C8-C683D34C6BC0Q42406515-70ABEF62-B118-466B-BACA-B5A60BDBFB09Q45325391-F1317003-8143-4357-8998-658E01EA6315
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Challenges in hepatitis B detection among blood donors.
@en
Challenges in hepatitis B detection among blood donors.
@nl
type
label
Challenges in hepatitis B detection among blood donors.
@en
Challenges in hepatitis B detection among blood donors.
@nl
prefLabel
Challenges in hepatitis B detection among blood donors.
@en
Challenges in hepatitis B detection among blood donors.
@nl
P1476
Challenges in hepatitis B detection among blood donors.
@en
P2093
Jean-Pierre Allain
P304
P356
10.1097/MOH.0B013E32834BAC10
P577
2011-11-01T00:00:00Z